CD274 and neoplasm: Epigenetic modulator therapy increases T-cell infiltration, decelerates tumor progression, and enhances the therapeutic efficacy of programmed death-ligand 1 (PD-L1) checkpoint blockade and adoptive T-cell transfusion.